191 related articles for article (PubMed ID: 27233365)
1. Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
Marcos E; Lazo L; Gil L; Izquierdo A; Suzarte E; Valdés I; Blanco A; Ancizar J; Alba JS; Pérez Yde L; Cobas K; Romero Y; Guillén G; Guzmán MG; Hermida L
Immunol Lett; 2016 Aug; 176():51-6. PubMed ID: 27233365
[TBL] [Abstract][Full Text] [Related]
2. A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.
Suzarte E; Gil L; Valdés I; Marcos E; Lazo L; Izquierdo A; García A; López L; Álvarez M; Pérez Y; Castro J; Romero Y; Guzmán MG; Guillén G; Hermida L
Int Immunol; 2015 Aug; 27(8):367-79. PubMed ID: 25795768
[TBL] [Abstract][Full Text] [Related]
3. Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.
Lauretti F; Chattopadhyay A; de Oliveira França RF; Castro-Jorge L; Rose J; Fonseca BA
Hum Vaccin Immunother; 2016 Sep; 12(9):2327-33. PubMed ID: 27185081
[TBL] [Abstract][Full Text] [Related]
4. A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
Valdés I; Marcos E; Suzarte E; Pérez Y; Brown E; Lazo L; Cobas K; Yaugel M; Rodríguez Y; Gil L; Guillén G; Hermida L
Arch Virol; 2017 Aug; 162(8):2247-2256. PubMed ID: 28393307
[TBL] [Abstract][Full Text] [Related]
5. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
6. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
7. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a Candidate DNA Vaccine Based on the prM/E Genes of a Dengue Type 2 Virus Cosmopolitan Genotype Strain.
Putri DH; Sudiro TM; Yunita R; Jaya UA; Dewi BE; Sjatha F; Konishi E; Hotta H; Sudarmono P
Jpn J Infect Dis; 2015; 68(5):357-63. PubMed ID: 25766602
[TBL] [Abstract][Full Text] [Related]
9. Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys.
Gil L; Izquierdo A; Lazo L; Valdés I; Ambala P; Ochola L; Marcos E; Suzarte E; Kariuki T; Guzmán G; Guillén G; Hermida L
Virology; 2014 May; 456-457():70-6. PubMed ID: 24889226
[TBL] [Abstract][Full Text] [Related]
10. Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice.
Gil L; López C; Lazo L; Valdés I; Marcos E; Alonso R; Gambe A; Martín J; Romero Y; Guzmán MG; Guillén G; Hermida L
Int Immunol; 2009 Oct; 21(10):1175-83. PubMed ID: 19692540
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques.
Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD
Vaccine; 2007 Jul; 25(29):5409-16. PubMed ID: 17560694
[TBL] [Abstract][Full Text] [Related]
12. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
Amorim JH; Pereira Bizerra RS; dos Santos Alves RP; Sbrogio-Almeida ME; Levi JE; Capurro ML; de Souza Ferreira LC
PLoS One; 2012; 7(9):e44984. PubMed ID: 23028722
[TBL] [Abstract][Full Text] [Related]
13. Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?
Valdés I; Gil L; Lazo L; Marcos E; Martín J; Suzarte E; Castro J; Romero Y; Guillén G; Hermida L
Arch Virol; 2016 Feb; 161(2):465-70. PubMed ID: 26590068
[TBL] [Abstract][Full Text] [Related]
14. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
15. Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model.
Amorim JH; dos Santos Alves RP; Bizerra R; Araújo Pereira S; Ramos Pereira L; Nascimento Fabris DL; Santos RA; Romano CM; de Souza Ferreira LC
Virology; 2016 Jan; 487():41-9. PubMed ID: 26496698
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
[TBL] [Abstract][Full Text] [Related]
17. Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.
Dayan GH; Galán-Herrera JF; Forrat R; Zambrano B; Bouckenooghe A; Harenberg A; Guy B; Lang J
Hum Vaccin Immunother; 2014; 10(10):2853-63. PubMed ID: 25483647
[TBL] [Abstract][Full Text] [Related]
18. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
19. Two complex, adenovirus-based vaccines that together induce immune responses to all four dengue virus serotypes.
Holman DH; Wang D; Raviprakash K; Raja NU; Luo M; Zhang J; Porter KR; Dong JY
Clin Vaccine Immunol; 2007 Feb; 14(2):182-9. PubMed ID: 17192403
[TBL] [Abstract][Full Text] [Related]
20. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
